Building our resilience to support patients

news ada

A cancer diagnosis can take a psychological toll on the individual and their family, with a rollercoaster of emotions along the way. Our patients have told us that their daily interactions with our team – whether it’s a welcoming smile on arrival or a chat over a coffee – can have a positive impact on what can be a sometimes testing journey.

To better support our teams to better support our patients, GenesisCare has partnered with clinical psychologist Dr Cath Adams to run a series of workshops focused on building resilience, eliciting and responding to emotional cues, and managing challenging conversations.

Our CancerCare Patient Experience Lead, Ada Ryan, said: “We monitor patient sentiment every month, and I’m always blown away by how much positive feedback there is for our teams. They have the most profound impact on the patient experience, so we are focused on looking for ways to better support them.”

The workshops were trialled in New South Wales and have been deemed an overwhelmingly success by participants. They will now be rolled out nationally.

GenesisCare recognises that the more positive and engaged our team are, the better the patient experience is. These types of initiatives help us continuously empower our team to deliver high quality care to patients.

International Clinical Trials Day May 20 2017

international clinical trials 800x320

Clinical research is the key to understanding complex diseases and to developing safe medicines and techniques to combat these diseases.

Each year, International Clinical Trials Day (ICTD) is celebrated around the world on or near May 20 to commemorate the day that James Lind began what is believed to be the world's first controlled clinical trial against the deadly disease scurvy. In 1747, he developed the theory that citrus fruits cured scurvy and the results of his trial saved the lives of thousands of sailors!1

Over one hundred years after Lind's findings the concepts used in modern clinical trials began to fully emerge:1

1863: Placebos (non-harmful ‘dummy’ or non-effective medical treatments) were given to control groups to compare the results against those of the new drug being tested.

Read more ...

You said, we did

you said people

Actions and outcomes taken as a result of consumer feedback

We don’t like to boast but we are very proud of our recent patient satisfactions ratings which have been steadily going from strength-to-strength in the last few months.
GenesisCare has twenty-seven treatment centres all over Australia where we treat people with a cancer diagnosis using radiation treatment.

Every month, people in our care kindly take the time to complete a patient satisfaction survey on an i-pad. The survey aims to find out how we can enhance our service and improve the patient experience. Reviewing individual comments in the patient satisfaction survey report is equally as important as reviewing the overall trends.

Read more ...

Major prostate cancer study finds radiation therapy comparable to surgical prostate removal

prostate cancer study

A major prostate cancer study, the ProtecT trial, has found that men with early prostate cancer have equivalent 10-year cancer-free survival results if they have radiation therapy or surgery, but that radiation therapy causes less urinary incontinence and sexual problems. The study also illustrates that the outcomes for patients with early stage prostate cancer are excellent across the board. Importantly, active surveillance is still a good option for some patients. The side-effect profile does differ between treatments, emphasising the importance of multidisciplinary care. Despite this, less than half of all Australian men with prostate cancer will see a radiation oncologist.

Read more ...

Follow us on Facebook

Genesis Logo Small.pngGenesisCare is Australia’s leading provider of radiation oncology, cardiology and sleep treatments. We exist to fill the treatment gap for the biggest disease burdens in Australia - cancer and heart care - in an environment of substantial unmet demand from an ageing population. Click here to learn more